Cite
HARVARD Citation
Chaplin, S. et al. (n.d.). Alogliptin – a new DPP‐4 inhibitor for type 2 diabetes. Prescriber. 25 (22), pp. 15-16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chaplin, S. et al. (n.d.). Alogliptin – a new DPP‐4 inhibitor for type 2 diabetes. Prescriber. 25 (22), pp. 15-16. [Online].